Moderna stock jumped 130% following a successful human trial for its skin cancer vaccine. The treatment proved effective even for late-stage melanoma patients.
2w
Moderna stock jumped 130% following a successful human trial for its skin cancer vaccine. The treatment proved effective even for late-stage melanoma patients.
2w
还没有评论。来抢沙发吧!
评论
还没有评论。来抢沙发吧!